English

NURX PHARMACEUTICALS, INC.

EDGAR

Quarterly report (10-Q) · filed 2010-08-23

33 filing records in this dataset, filed from 2003-05-13 to 2010-08-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

580 thousand USD

2007-03-31 · USD

Exact inputs and evidence

Revenue: 580256 USD Source

Operating margin

-0.12%

2007-03-31 · %

Exact inputs and evidence

Operating Income: -671 USD Source
Revenue: 580256 USD Source

Operating cash flow

94.1 thousand USD

2007-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 106767 USD Source
Operating Cash Flow: 12619 USD Source

Free cash flow

92.6 thousand USD

2007-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 106767 USD Source
Operating Cash Flow: 12619 USD Source
Capital Expenditure: 1500 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 219 thousand USD 2010-06-30 Source
Exact value

218906 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.39 million USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Revenue: 655812 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 2422691 USD · 2005-10-01 – 2006-09-30 Source
Revenue: 1883126 USD · 2005-10-01 – 2006-06-30 Source
Revenue: 617358 USD · 2006-10-01 – 2006-12-31 Source
Revenue: 580256 USD · 2007-01-01 – 2007-03-31 Source

Operating cash flow

121 thousand USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Operating cash flow: 249459 USD · 2005-10-01 – 2006-06-30 Source
Operating cash flow: 166889 USD · 2005-10-01 – 2006-03-31 Source
Operating cash flow: 181390 USD · 2005-10-01 – 2006-09-30 Source
Operating cash flow: 249459 USD · 2005-10-01 – 2006-06-30 Source
Operating cash flow: 12619 USD · 2006-10-01 – 2006-12-31 Source
Operating cash flow: 106767 USD · 2006-10-01 – 2007-03-31 Source
Operating cash flow: 12619 USD · 2006-10-01 – 2006-12-31 Source

Capital expenditure

6.3 thousand USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Capital expenditure: 9157 USD · 2005-10-01 – 2006-06-30 Source
Capital expenditure: 8357 USD · 2005-10-01 – 2006-03-31 Source
Capital expenditure: 13157 USD · 2005-10-01 – 2006-09-30 Source
Capital expenditure: 9157 USD · 2005-10-01 – 2006-06-30 Source
Capital expenditure: 0 USD · 2006-10-01 – 2006-12-31 Source
Capital expenditure: 1500 USD · 2006-10-01 – 2007-03-31 Source
Capital expenditure: 0 USD · 2006-10-01 – 2006-12-31 Source

Free cash flow

115 thousand USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Operating cash flow: 249459 USD · 2005-10-01 – 2006-06-30 Source
Operating cash flow: 166889 USD · 2005-10-01 – 2006-03-31 Source
Operating cash flow: 181390 USD · 2005-10-01 – 2006-09-30 Source
Operating cash flow: 249459 USD · 2005-10-01 – 2006-06-30 Source
Operating cash flow: 12619 USD · 2006-10-01 – 2006-12-31 Source
Operating cash flow: 106767 USD · 2006-10-01 – 2007-03-31 Source
Operating cash flow: 12619 USD · 2006-10-01 – 2006-12-31 Source
Capital expenditure: 9157 USD · 2005-10-01 – 2006-06-30 Source
Capital expenditure: 8357 USD · 2005-10-01 – 2006-03-31 Source
Capital expenditure: 13157 USD · 2005-10-01 – 2006-09-30 Source
Capital expenditure: 9157 USD · 2005-10-01 – 2006-06-30 Source
Capital expenditure: 0 USD · 2006-10-01 – 2006-12-31 Source
Capital expenditure: 1500 USD · 2006-10-01 – 2007-03-31 Source
Capital expenditure: 0 USD · 2006-10-01 – 2006-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-08-23.

Financial data available through: 2006-09-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2006-09-30
Operating income: 5 of 11 periods available· newest 2006-09-30
Net income: 5 of 11 periods available· newest 2006-09-30
Operating cash flow: 5 of 11 periods available· newest 2006-09-30
Capital expenditure: 3 of 11 periods available· newest 2006-09-30
Total assets: 5 of 11 periods available· newest 2006-09-30
Total liabilities: 5 of 11 periods available· newest 2006-09-30
Current assets: 5 of 11 periods available· newest 2006-09-30
Current liabilities: 5 of 11 periods available· newest 2006-09-30
Cash and cash equivalents: 5 of 11 periods available· newest 2006-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+24.6%

Prior period

USD 1.94 million

2004-10-01 – 2005-09-30
Current period

USD 2.42 million

2005-10-01 – 2006-09-30

Exact inputs and evidence

2422691 − 1943721 = 478970 USD

1943721 USD · 2004-10-01 – 2005-09-30
Inspect prior input Prior source
2422691 USD · 2005-10-01 – 2006-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Year-over-year change in Revenue: 478970 USD Concept: fundies:Revenue Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2422691 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#3382 Input fundies:Revenue: 1943721 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#3382
The citation records this snapshot. The page link may show a newer release later.
Net income
+35.6%

Prior period

USD 142,088

2004-10-01 – 2005-09-30
Current period

USD 192,703

2005-10-01 – 2006-09-30

Exact inputs and evidence

192703 − 142088 = 50615 USD

142088 USD · 2004-10-01 – 2005-09-30
Inspect prior input Prior source
192703 USD · 2005-10-01 – 2006-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Year-over-year change in Net income: 50615 USD Concept: fundies:NetIncome Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 192703 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4621 Input fundies:NetIncome: 142088 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4621
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+120.5%

Prior period

USD 82,267

2004-10-01 – 2005-09-30
Current period

USD 181,390

2005-10-01 – 2006-09-30

Exact inputs and evidence

181390 − 82267 = 99123 USD

82267 USD · 2004-10-01 – 2005-09-30
Inspect prior input Prior source
181390 USD · 2005-10-01 – 2006-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Year-over-year change in Operating cash flow: 99123 USD Concept: fundies:OperatingCashFlow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 181390 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797 Input fundies:OperatingCashFlow: 82267 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+135.8%

Prior period

USD 5,579

2004-10-01 – 2005-09-30
Current period

USD 13,157

2005-10-01 – 2006-09-30

Exact inputs and evidence

13157 − 5579 = 7578 USD

5579 USD · 2004-10-01 – 2005-09-30
Inspect prior input Prior source
13157 USD · 2005-10-01 – 2006-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Year-over-year change in Capital expenditure: 7578 USD Concept: fundies:CapitalExpenditure Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13157 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830 Input fundies:CapitalExpenditure: 5579 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2005-10-01 – 2006-09-30

Revenue USD 2.42 million 100% of revenue
Operating costs Derived USD 2.17 million 90% of revenue
Operating income USD 251,551 10% of revenue
Tax, interest and other Derived USD 58,848 2.4% of revenue
Net income USD 192,703 8% of revenue

Cash

Operating cash flow USD 181,390 7.5% of revenue
Capital expenditure USD 13,157 0.5% of revenue
Free cash flow Derived USD 168,233 6.9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 139% of revenue.
2003 Operating loss: operating costs were 103% of revenue.
2004 Net income was higher than operating income, so the split is not drawn.
2005 88%
2006 90%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2001-10-01 – 2002-09-30	480231	665560 Derived	-185329	10244 Derived	-195573	Unavailable	Source 2001-10-01 – 2002-09-30: 480231 USD Inspect Revenue Open source 2001-10-01 – 2002-09-30: -185329 USD Inspect Operating Income Open source 2001-10-01 – 2002-09-30: -195573 USD Inspect Net Income Open source 2001-10-01 – 2002-09-30: -81967 USD Inspect Operating Cash Flow Open source
2003 2002-10-01 – 2003-09-30	817440	841472 Derived	-24032	12330 Derived	-36362	Unavailable	Source 2002-10-01 – 2003-09-30: 817440 USD Inspect Revenue Open source 2002-10-01 – 2003-09-30: -24032 USD Inspect Operating Income Open source 2002-10-01 – 2003-09-30: -36362 USD Inspect Net Income Open source 2002-10-01 – 2003-09-30: 29339 USD Inspect Operating Cash Flow Open source
2004 2003-10-01 – 2004-09-30	1305960	1268562 Derived	37398	-74997 Derived	112395	7614 Derived	Source 2003-10-01 – 2004-09-30: 1305960 USD Inspect Revenue Open source 2003-10-01 – 2004-09-30: 37398 USD Inspect Operating Income Open source 2003-10-01 – 2004-09-30: 112395 USD Inspect Net Income Open source 2003-10-01 – 2004-09-30: 13374 USD Inspect Operating Cash Flow Open source 2003-10-01 – 2004-09-30: 5760 USD Inspect Capital Expenditure Open source
2005 2004-10-01 – 2005-09-30	1943721	1712892 Derived	230829	88741 Derived	142088	76688 Derived	Source 2004-10-01 – 2005-09-30: 1943721 USD Inspect Revenue Open source 2004-10-01 – 2005-09-30: 230829 USD Inspect Operating Income Open source 2004-10-01 – 2005-09-30: 142088 USD Inspect Net Income Open source 2004-10-01 – 2005-09-30: 82267 USD Inspect Operating Cash Flow Open source 2004-10-01 – 2005-09-30: 5579 USD Inspect Capital Expenditure Open source
2006 2005-10-01 – 2006-09-30	2422691	2171140 Derived	251551	58848 Derived	192703	168233 Derived	Source 2005-10-01 – 2006-09-30: 2422691 USD Inspect Revenue Open source 2005-10-01 – 2006-09-30: 251551 USD Inspect Operating Income Open source 2005-10-01 – 2006-09-30: 192703 USD Inspect Net Income Open source 2005-10-01 – 2006-09-30: 181390 USD Inspect Operating Cash Flow Open source 2005-10-01 – 2006-09-30: 13157 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.4M 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Revenue	480231	Revenue: 480231 Open source
20032003-09-30	Revenue	817440	Revenue: 817440 Open source
20042004-09-30	Revenue	1305960	Revenue: 1305960 Open source
20052005-09-30	Revenue	1943721	Revenue: 1943721 Open source
20062006-09-30	Revenue	2422691	Revenue: 2422691 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

24.6% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Year over year	No prior comparable period	Revenue: 480231 Open source
20032003-09-30	Year over year	70.2%	Revenue: 817440 Open source Revenue: 480231 Open source
20042004-09-30	Year over year	59.8%	Revenue: 1305960 Open source Revenue: 817440 Open source
20052005-09-30	Year over year	48.8%	Revenue: 1943721 Open source Revenue: 1305960 Open source
20062006-09-30	Year over year	24.6%	Revenue: 2422691 Open source Revenue: 1943721 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.4% 2006

Net margin 8% 2006

Free cash flow margin 6.9% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Operating margin	-38.6%	Operating Income: -185329 Open source Revenue: 480231 Open source
20032003-09-30	Operating margin	-2.9%	Operating Income: -24032 Open source Revenue: 817440 Open source
20042004-09-30	Operating margin	2.9%	Operating Income: 37398 Open source Revenue: 1305960 Open source
20052005-09-30	Operating margin	11.9%	Operating Income: 230829 Open source Revenue: 1943721 Open source
20062006-09-30	Operating margin	10.4%	Operating Income: 251551 Open source Revenue: 2422691 Open source
20022002-09-30	Net margin	-40.7%	Net Income: -195573 Open source Revenue: 480231 Open source
20032003-09-30	Net margin	-4.4%	Net Income: -36362 Open source Revenue: 817440 Open source
20042004-09-30	Net margin	8.6%	Net Income: 112395 Open source Revenue: 1305960 Open source
20052005-09-30	Net margin	7.3%	Net Income: 142088 Open source Revenue: 1943721 Open source
20062006-09-30	Net margin	8%	Net Income: 192703 Open source Revenue: 2422691 Open source
20022002-09-30	Free cash flow margin	Not reported	Revenue: 480231 Open source Operating Cash Flow: -81967 Open source
20032003-09-30	Free cash flow margin	Not reported	Revenue: 817440 Open source Operating Cash Flow: 29339 Open source
20042004-09-30	Free cash flow margin	0.6%	Revenue: 1305960 Open source Operating Cash Flow: 13374 Open source Capital Expenditure: 5760 Open source
20052005-09-30	Free cash flow margin	3.9%	Revenue: 1943721 Open source Operating Cash Flow: 82267 Open source Capital Expenditure: 5579 Open source
20062006-09-30	Free cash flow margin	6.9%	Revenue: 2422691 Open source Operating Cash Flow: 181390 Open source Capital Expenditure: 13157 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 181.4K 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Operating cash flow	-81967	Operating Cash Flow: -81967 Open source
20032003-09-30	Operating cash flow	29339	Operating Cash Flow: 29339 Open source
20042004-09-30	Operating cash flow	13374	Operating Cash Flow: 13374 Open source
20052005-09-30	Operating cash flow	82267	Operating Cash Flow: 82267 Open source
20062006-09-30	Operating cash flow	181390	Operating Cash Flow: 181390 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 168.2K 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Free cash flow	Unavailable	Operating Cash Flow: -81967 Open source
20032003-09-30	Free cash flow	Unavailable	Operating Cash Flow: 29339 Open source
20042004-09-30	Free cash flow	7614	Operating Cash Flow: 13374 Open source Capital Expenditure: 5760 Open source
20052005-09-30	Free cash flow	76688	Operating Cash Flow: 82267 Open source Capital Expenditure: 5579 Open source
20062006-09-30	Free cash flow	168233	Operating Cash Flow: 181390 Open source Capital Expenditure: 13157 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

29.6% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Liabilities / assets	313.9%	Total Liabilities: 242111 Open source Total Assets: 77141 Open source
20032003-09-30	Liabilities / assets	246.7%	Total Liabilities: 338569 Open source Total Assets: 137237 Open source
20042004-09-30	Liabilities / assets	117%	Total Liabilities: 358386 Open source Total Assets: 306249 Open source
20052005-09-30	Liabilities / assets	77.7%	Total Liabilities: 313933 Open source Total Assets: 403884 Open source
20062006-09-30	Liabilities / assets	29.6%	Total Liabilities: 119081 Open source Total Assets: 401735 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.37× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Current assets / current liabilities	0.41×	Current Assets: 71039 Open source Current Liabilities: 172084 Open source
20032003-09-30	Current assets / current liabilities	1.16×	Current Assets: 128625 Open source Current Liabilities: 110569 Open source
20042004-09-30	Current assets / current liabilities	1.11×	Current Assets: 225930 Open source Current Liabilities: 203386 Open source
20052005-09-30	Current assets / current liabilities	1.25×	Current Assets: 391886 Open source Current Liabilities: 313933 Open source
20062006-09-30	Current assets / current liabilities	3.37×	Current Assets: 401735 Open source Current Liabilities: 119081 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-10-01 – 2002-09-30	−USD 195,573 Exact value Exact value: -195573 USD 2001-10-01 – 2002-09-30: -195573 USD Inspect Net Income Open source Share or cite Citation for Net Income · NURX PHARMACEUTICALS, INC. · 2002-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Net Income: -195573 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -195573 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-03-000773.txt#1865 The citation records this snapshot. The page link may show a newer release later.	−USD 81,967 Exact value Exact value: -81967 USD 2001-10-01 – 2002-09-30: -81967 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NURX PHARMACEUTICALS, INC. · 2002-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Operating Cash Flow: -81967 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3AOperatingCashFlow&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81967 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-03-000773.txt#1882 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2002-10-01 – 2003-09-30	−USD 36,362 Exact value Exact value: -36362 USD 2002-10-01 – 2003-09-30: -36362 USD Inspect Net Income Open source Share or cite Citation for Net Income · NURX PHARMACEUTICALS, INC. · 2003-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Net Income: -36362 USD Concept: fundies:NetIncome Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ANetIncome&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:NetIncome: -36362 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-04-001198.txt#1895 The citation records this snapshot. The page link may show a newer release later.	USD 29,339 Exact value Exact value: 29339 USD 2002-10-01 – 2003-09-30: 29339 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NURX PHARMACEUTICALS, INC. · 2003-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Operating Cash Flow: 29339 USD Concept: fundies:OperatingCashFlow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3AOperatingCashFlow&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 29339 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-04-001198.txt#1912 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2003-10-01 – 2004-09-30	USD 112,395 Exact value Exact value: 112395 USD 2003-10-01 – 2004-09-30: 112395 USD Inspect Net Income Open source Share or cite Citation for Net Income · NURX PHARMACEUTICALS, INC. · 2004-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Net Income: 112395 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ANetIncome&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:NetIncome: 112395 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-05-001071.txt#1879 The citation records this snapshot. The page link may show a newer release later.	USD 13,374 Exact value Exact value: 13374 USD 2003-10-01 – 2004-09-30: 13374 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NURX PHARMACEUTICALS, INC. · 2004-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Operating Cash Flow: 13374 USD Concept: fundies:OperatingCashFlow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3AOperatingCashFlow&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 13374 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-05-001071.txt#1896 The citation records this snapshot. The page link may show a newer release later.	USD 5,760 Exact value Exact value: 5760 USD 2003-10-01 – 2004-09-30: 5760 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NURX PHARMACEUTICALS, INC. · 2004-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Capital Expenditure: 5760 USD Concept: fundies:CapitalExpenditure Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ACapitalExpenditure&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5760 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-05-001071.txt#1900 The citation records this snapshot. The page link may show a newer release later.	USD 7,614 Calculation and evidence 13374 − 5760 USD Exact free cash flow: 7614 USD 2003-10-01 – 2004-09-30: 13374 USD · Inspect Operating Cash Flow · Source 2003-10-01 – 2004-09-30: 5760 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NURX PHARMACEUTICALS, INC. · 2004-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Free cash flow: 7614 USD Concept: free-cash-flow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13374 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-05-001071.txt#1896 Input fundies:CapitalExpenditure: 5760 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-05-001071.txt#1900 The citation records this snapshot. The page link may show a newer release later.
2005 2004-10-01 – 2005-09-30	USD 142,088 Exact value Exact value: 142088 USD 2004-10-01 – 2005-09-30: 142088 USD Inspect Net Income Open source Share or cite Citation for Net Income · NURX PHARMACEUTICALS, INC. · 2005-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Net Income: 142088 USD Concept: fundies:NetIncome Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ANetIncome&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:NetIncome: 142088 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4621 The citation records this snapshot. The page link may show a newer release later.	USD 82,267 Exact value Exact value: 82267 USD 2004-10-01 – 2005-09-30: 82267 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NURX PHARMACEUTICALS, INC. · 2005-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Operating Cash Flow: 82267 USD Concept: fundies:OperatingCashFlow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3AOperatingCashFlow&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 82267 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797 The citation records this snapshot. The page link may show a newer release later.	USD 5,579 Exact value Exact value: 5579 USD 2004-10-01 – 2005-09-30: 5579 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NURX PHARMACEUTICALS, INC. · 2005-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Capital Expenditure: 5579 USD Concept: fundies:CapitalExpenditure Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ACapitalExpenditure&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5579 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830 The citation records this snapshot. The page link may show a newer release later.	USD 76,688 Calculation and evidence 82267 − 5579 USD Exact free cash flow: 76688 USD 2004-10-01 – 2005-09-30: 82267 USD · Inspect Operating Cash Flow · Source 2004-10-01 – 2005-09-30: 5579 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NURX PHARMACEUTICALS, INC. · 2005-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Free cash flow: 76688 USD Concept: free-cash-flow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 82267 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797 Input fundies:CapitalExpenditure: 5579 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830 The citation records this snapshot. The page link may show a newer release later.
2006 2005-10-01 – 2006-09-30	USD 192,703 Exact value Exact value: 192703 USD 2005-10-01 – 2006-09-30: 192703 USD Inspect Net Income Open source Share or cite Citation for Net Income · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Net Income: 192703 USD Concept: fundies:NetIncome Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ANetIncome&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:NetIncome: 192703 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4621 The citation records this snapshot. The page link may show a newer release later.	USD 181,390 Exact value Exact value: 181390 USD 2005-10-01 – 2006-09-30: 181390 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Operating Cash Flow: 181390 USD Concept: fundies:OperatingCashFlow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3AOperatingCashFlow&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 181390 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797 The citation records this snapshot. The page link may show a newer release later.	USD 13,157 Exact value Exact value: 13157 USD 2005-10-01 – 2006-09-30: 13157 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Capital Expenditure: 13157 USD Concept: fundies:CapitalExpenditure Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228/explain?concept=fundies%3ACapitalExpenditure&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13157 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830 The citation records this snapshot. The page link may show a newer release later.	USD 168,233 Calculation and evidence 181390 − 13157 USD Exact free cash flow: 168233 USD 2005-10-01 – 2006-09-30: 181390 USD · Inspect Operating Cash Flow · Source 2005-10-01 – 2006-09-30: 13157 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NURX PHARMACEUTICALS, INC. · 2006-09-30 NURX PHARMACEUTICALS, INC. (edgar:1174228) Free cash flow: 168233 USD Concept: free-cash-flow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1174228?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 181390 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4797 Input fundies:CapitalExpenditure: 13157 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1174228/0001038838-06-000952.txt#4830 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001174228, 1174228, edgar:1174228

Also known as QUEST GROUP INTERNATIONAL INC

NURX PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2005-10-01 – 2006-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation